• Questions
  • Tournaments
  • Services
  • News
  • Questions
  • Tournaments
  • Questions
  • Questions
Question

Will a senolytic therapy be approved for commercial sale by the US FDA before January 1, 2030?

42
34 comments34
Total Forecasters152
Community Prediction
54%
(47% - 62%)

Make a Prediction

50%
community: 54%
No key factors yetAdd some that might influence this forecast.
Add key factor
Authors:
Jgalt
Opened:Dec 11, 2018
Closes:Jan 1, 2030
Scheduled resolution:Jan 1, 2030
Spot Scoring Time:Dec 13, 2018
Economy & Business
Natural Sciences
Social Sciences
Technology
Health & Pandemics
Novo Nordisk Advances Promising Weight Loss Drug Amycretin to Final Testing Stage After Strong Trial Results
•Jun 22, 2025
Independent logo
Scientists confirm breakthrough in search for ways to extend human life
Independent•Jun 19, 2025
Biotech Stocks Facing FDA Decision In June 2025
•Jun 18, 2025
Learn more about Metaculus NewsMatch

Will a senolytic therapy for a companion animal be commercially available before one for humans?

70%

Before January 1, 2032, will an FDA-approved therapeutic intervention demonstrate a statistically significant reversal of at least 10 years in biological age in humans?

20%

Will an FDA-approved diagnostic test that predicts individual response to longevity interventions be commercially available and covered by insurers by January 1, 2030?

55%
Authors:
Jgalt
Opened:Dec 11, 2018
Closes:Jan 1, 2030
Scheduled resolution:Jan 1, 2030
Spot Scoring Time:Dec 13, 2018
Economy & Business
Natural Sciences
Social Sciences
Technology
Health & Pandemics
Novo Nordisk Advances Promising Weight Loss Drug Amycretin to Final Testing Stage After Strong Trial Results
•Jun 22, 2025
Independent logo
Scientists confirm breakthrough in search for ways to extend human life
Independent•Jun 19, 2025
Biotech Stocks Facing FDA Decision In June 2025
•Jun 18, 2025
Learn more about Metaculus NewsMatch

Will a senolytic therapy for a companion animal be commercially available before one for humans?

70%

Before January 1, 2032, will an FDA-approved therapeutic intervention demonstrate a statistically significant reversal of at least 10 years in biological age in humans?

20%

Will an FDA-approved diagnostic test that predicts individual response to longevity interventions be commercially available and covered by insurers by January 1, 2030?

55%
  • About
  • API
  • FAQ
  • forecasting resources
  • For Journalists
  • Contact
  • Careers
GuidelinesPrivacy PolicyTerms of Use
ForbesScientific AmericanTimeVoxYale NewsNature